Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Young Woman in the Breast Clinic: Ultrasound or Not?

Kaminsky O, Abdul Halim N, Zilbermints V, Sharon E, Aranovich D.

Isr Med Assoc J. 2019 Sep;21(9):612-614.

2.

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.

Khodadoust MS, Rook AH, Porcu P, Foss F, Moskowitz AJ, Shustov A, Shanbhag S, Sokol L, Fling SP, Ramchurren N, Pierce R, Davis A, Shine R, Li S, Fong S, Kim J, Yang Y, Blumenschein WM, Yearley JH, Das B, Patidar R, Datta V, Cantu E, McCutcheon JN, Karlovich C, Williams PM, Subrahmanyam PB, Maecker HT, Horwitz SM, Sharon E, Kohrt HE, Cheever MA, Kim YH.

J Clin Oncol. 2019 Sep 18:JCO1901056. doi: 10.1200/JCO.19.01056. [Epub ahead of print]

PMID:
31532724
3.

Publisher Correction: Shape and fluctuations of frustrated self-assembled nano ribbons.

Zhang M, Grossman D, Danino D, Sharon E.

Nat Commun. 2019 Sep 13;10(1):4245. doi: 10.1038/s41467-019-12300-8.

4.

Ado-trastuzumab emtansine (T-DM1) in patients with HER2 amplified tumors excluding breast and gastric/gastro-esophageal junction (GEJ) adenocarcinomas: Results from the NCI-MATCH Trial (EAY131) Sub-protocol Q.

Jhaveri KL, Wang XV, Makker V, Luoh SW, Mitchell EP, Zwiebel JA, Sharon E, Gray RJ, Li S, McShane LM, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT.

Ann Oncol. 2019 Aug 27. pii: mdz291. doi: 10.1093/annonc/mdz291. [Epub ahead of print]

PMID:
31504139
5.

Pediatric and Adolescent Surgical Breast Clinic - Preliminary Experience.

Cohen O, Avinadav E, Sharon E, Pirogovsky A, Freud E.

J Pediatr Adolesc Gynecol. 2019 Aug 21. pii: S1083-3188(19)30266-9. doi: 10.1016/j.jpag.2019.08.010. [Epub ahead of print]

PMID:
31445140
6.

Shape and fluctuations of frustrated self-assembled nano ribbons.

Zhang M, Grossman D, Danino D, Sharon E.

Nat Commun. 2019 Aug 8;10(1):3565. doi: 10.1038/s41467-019-11473-6. Erratum in: Nat Commun. 2019 Sep 13;10(1):4245.

7.

An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer.

Stewart M, Norden AD, Dreyer N, Henk HJ, Abernethy AP, Chrischilles E, Kushi L, Mansfield AS, Khozin S, Sharon E, Arunajadai S, Carnahan R, Christian JB, Miksad RA, Sakoda LC, Torres AZ, Valice E, Allen J.

JCO Clin Cancer Inform. 2019 Jul;3:1-15. doi: 10.1200/CCI.18.00155.

8.

A nouveau collagen scaffold to simplify lateral augmentation of deficient ridges between natural teeth.

Smidt A, Gutmacher Z, Sharon E.

Quintessence Int. 2019;50(7):576-582. doi: 10.3290/j.qi.a42652.

PMID:
31161157
9.

Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study.

Uldrick TS, Gonçalves PH, Abdul-Hay M, Claeys AJ, Emu B, Ernstoff MS, Fling SP, Fong L, Kaiser JC, Lacroix AM, Lee SY, Lundgren LM, Lurain K, Parsons CH, Peeramsetti S, Ramaswami R, Sharon E, Sznol M, Wang CJ, Yarchoan R, Cheever MA; Cancer Immunotherapy Trials Network (CITN)-12 Study Team.

JAMA Oncol. 2019 Jun 2. doi: 10.1001/jamaoncol.2019.2244. [Epub ahead of print]

PMID:
31154457
10.

Report on the 2018 Cancer, Autoimmunity, and Immunology Conference.

Curran CS, Sommers CL, Young HA, Bourcier K, Mancini M, Sharon E.

J Immunol. 2019 May 15;202(10):2823-2828. doi: 10.4049/jimmunol.1900264. Epub 2019 Apr 15.

PMID:
30988117
11.

Current Landscape of Immunotherapy in Breast Cancer: A Review.

Adams S, Gatti-Mays ME, Kalinsky K, Korde LA, Sharon E, Amiri-Kordestani L, Bear H, McArthur HL, Frank E, Perlmutter J, Page DB, Vincent B, Hayes JF, Gulley JL, Litton JK, Hortobagyi GN, Chia S, Krop I, White J, Sparano J, Disis ML, Mittendorf EA.

JAMA Oncol. 2019 Apr 11. doi: 10.1001/jamaoncol.2018.7147. [Epub ahead of print]

PMID:
30973611
12.

Influence of jaw opening on occlusal vertical dimension between incisors and molars.

Sharon E, Beyth N, Smidt A, Lipovetsky-Adler M, Zilberberg N.

J Prosthet Dent. 2019 Aug;122(2):115-118. doi: 10.1016/j.prosdent.2018.10.010. Epub 2019 Mar 15.

PMID:
30885579
13.

Antibacterial Orthodontic Cements and Adhesives: A Possible Solution to Streptococcus mutans Outgrowth Adjacent to Orthodontic Appliances.

Varon-Shahar E, Sharon E, Zabrovsky A, Houri-Haddad Y, Beyth N.

Oral Health Prev Dent. 2019;17(1):49-56. doi: 10.3290/j.ohpd.a41983.

PMID:
30793122
14.

Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.

Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Brohl AS, Friedlander PA, Daud A, Kluger HM, Reddy SA, Boulmay BC, Riker AI, Burgess MA, Hanks BA, Olencki T, Margolin K, Lundgren LM, Soni A, Ramchurren N, Church C, Park SY, Shinohara MM, Salim B, Taube JM, Bird SR, Ibrahim N, Fling SP, Homet Moreno B, Sharon E, Cheever MA, Topalian SL.

J Clin Oncol. 2019 Mar 20;37(9):693-702. doi: 10.1200/JCO.18.01896. Epub 2019 Feb 6.

PMID:
30726175
15.

Tuberculosis following PD-1 blockade for cancer immunotherapy.

Barber DL, Sakai S, Kudchadkar RR, Fling SP, Day TA, Vergara JA, Ashkin D, Cheng JH, Lundgren LM, Raabe VN, Kraft CS, Nieva JJ, Cheever MA, Nghiem PT, Sharon E.

Sci Transl Med. 2019 Jan 16;11(475). pii: eaat2702. doi: 10.1126/scitranslmed.aat2702.

PMID:
30651320
16.

Systematic interrogation of human promoters.

Weingarten-Gabbay S, Nir R, Lubliner S, Sharon E, Kalma Y, Weinberger A, Segal E.

Genome Res. 2019 Feb;29(2):171-183. doi: 10.1101/gr.236075.118. Epub 2019 Jan 8.

17.

Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes.

Tray N, Taff J, Singh B, Suh J, Ngo N, Kwa M, Troxel AB, Chae YK, Kurzrock R, Patel SP, Sharon E, Denkert C, Ross JS, Adams S.

Breast. 2019 Apr;44:29-32. doi: 10.1016/j.breast.2018.12.010. Epub 2018 Dec 20.

18.

Twist renormalization in molecular crystals driven by geometric frustration.

Haddad A, Aharoni H, Sharon E, Shtukenberg AG, Kahr B, Efrati E.

Soft Matter. 2018 Dec 19;15(1):116-126. doi: 10.1039/c8sm01290c.

PMID:
30534682
19.

PD-1 immunobiology in systemic lupus erythematosus.

Curran CS, Gupta S, Sanz I, Sharon E.

J Autoimmun. 2019 Feb;97:1-9. doi: 10.1016/j.jaut.2018.10.025. Epub 2018 Nov 3. Review.

PMID:
30396745
20.

Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement.

Tsimberidou AM, Levit LA, Schilsky RL, Averbuch SD, Chen D, Kirkwood JM, McShane LM, Sharon E, Mileham KF, Postow MA.

J Immunother Cancer. 2018 Oct 19;6(1):108. doi: 10.1186/s40425-018-0426-7.

21.

Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement.

Tsimberidou AM, Levit LA, Schilsky RL, Averbuch SD, Chen D, Kirkwood JM, McShane LM, Sharon E, Mileham KF, Postow MA.

J Clin Oncol. 2019 Jan 1;37(1):72-80. doi: 10.1200/JCO.18.00145. Epub 2018 Oct 19.

22.

Shape and fluctuations of positively curved ribbons.

Grossman D, Sharon E, Katzav E.

Phys Rev E. 2018 Aug;98(2-1):022502. doi: 10.1103/PhysRevE.98.022502.

PMID:
30253468
23.

Functional Genetic Variants Revealed by Massively Parallel Precise Genome Editing.

Sharon E, Chen SA, Khosla NM, Smith JD, Pritchard JK, Fraser HB.

Cell. 2018 Oct 4;175(2):544-557.e16. doi: 10.1016/j.cell.2018.08.057. Epub 2018 Sep 20.

24.

Species-complex diversification and host-plant associations in Bemisia tabaci: A plant-defence, detoxification perspective revealed by RNA-Seq analyses.

Malka O, Santos-Garcia D, Feldmesser E, Sharon E, Krause-Sakate R, Delatte H, van Brunschot S, Patel M, Visendi P, Mugerwa H, Seal S, Colvin J, Morin S.

Mol Ecol. 2018 Nov;27(21):4241-4256. doi: 10.1111/mec.14865. Epub 2018 Oct 10.

25.

The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management.

Girotra M, Hansen A, Farooki A, Byun DJ, Min L, Creelan BC, Callahan MK, Atkins MB, Sharon E, Antonia SJ, West P, Gravell AE; Investigational Drug Steering Committee (IDSC) Immunotherapy Task Force collaboration.

JNCI Cancer Spectr. 2018 Jul;2(3):pky021. doi: 10.1093/jncics/pky021. Epub 2018 Jul 19. Review.

26.

PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma.

Curran CS, Sharon E.

Semin Oncol. 2017 Dec;44(6):428-432. doi: 10.1053/j.seminoncol.2017.12.001. Epub 2018 Jan 6. Review.

27.

Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.

Haldar R, Shaashua L, Lavon H, Lyons YA, Zmora O, Sharon E, Birnbaum Y, Allweis T, Sood AK, Barshack I, Cole S, Ben-Eliyahu S.

Brain Behav Immun. 2018 Oct;73:294-309. doi: 10.1016/j.bbi.2018.05.014. Epub 2018 May 22.

PMID:
29800703
28.

Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?

Ben-Aharon I, Levi M, Margel D, Yerushalmi R, Rizel S, Perry S, Sharon E, Hasky N, Abir R, Fisch B, Tobar A, Shalgi R, Stemmer SM.

Oncotarget. 2018 Mar 23;9(22):15931-15941. doi: 10.18632/oncotarget.24638. eCollection 2018 Mar 23.

29.

Antibacterial Activity of Orthodontic Cement Containing Quaternary Ammonium Polyethylenimine Nanoparticles Adjacent to Orthodontic Brackets.

Sharon E, Sharabi R, Eden A, Zabrovsky A, Ben-Gal G, Sharon E, Pietrokovski Y, Houri-Haddad Y, Beyth N.

Int J Environ Res Public Health. 2018 Mar 27;15(4). pii: E606. doi: 10.3390/ijerph15040606.

30.

Report on the NCI Microbial-Based Cancer Therapy Conference.

Curran CS, Rasooly A, He M, Prickril B, Thurin M, Sharon E.

Cancer Immunol Res. 2018 Feb;6(2):122-126. doi: 10.1158/2326-6066.CIR-17-0748.

31.

Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma.

Rubinstein PG, Moore PC, Rudek MA, Henry DH, Ramos JC, Ratner L, Reid E, Sharon E, Noy A; AIDS Malignancy Consortium (AMC).

AIDS. 2018 Mar 13;32(5):605-611. doi: 10.1097/QAD.0000000000001729.

32.

Patterns of care and survival among patients with malignant mesothelioma in the United States.

Enewold L, Sharon E, Thomas A.

Lung Cancer. 2017 Oct;112:102-108. doi: 10.1016/j.lungcan.2017.08.009. Epub 2017 Aug 10.

33.

Guest Editorial: The X-1 concept.

Sharon E, Smidt A.

Quintessence Int. 2017;48(9):687-688. doi: 10.3290/j.qi.a38974. No abstract available.

PMID:
28920108
34.

From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely.

Day D, Monjazeb AM, Sharon E, Ivy SP, Rubin EH, Rosner GL, Butler MO.

Clin Cancer Res. 2017 Sep 1;23(17):4980-4991. doi: 10.1158/1078-0432.CCR-16-3064.

35.

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity.

Anagnostou V, Yarchoan M, Hansen AR, Wang H, Verde F, Sharon E, Collyar D, Chow LQM, Forde PM.

Clin Cancer Res. 2017 Sep 1;23(17):4959-4969. doi: 10.1158/1078-0432.CCR-16-3065.

36.

Immune Modulation Therapy and Imaging: Workshop Report.

Shields AF, Jacobs PM, Sznol M, Graham MM, Germain RN, Lum LG, Jaffee EM, de Vries EGE, Nimmagadda S, Van den Abbeele AD, Leung DK, Wu AM, Sharon E, Shankar LK.

J Nucl Med. 2018 Mar;59(3):410-417. doi: 10.2967/jnumed.117.195610. Epub 2017 Aug 17.

37.

Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype.

Sharon E, Shi H, Kharbanda S, Koh W, Martin LR, Khush KK, Valantine H, Pritchard JK, De Vlaminck I.

PLoS Comput Biol. 2017 Aug 3;13(8):e1005629. doi: 10.1371/journal.pcbi.1005629. eCollection 2017 Aug.

38.

[PARTIAL BREAST RECONSTRUCTION BY MODIFIED BREAST REDUCTION TECHNIQUES].

Ad-El DD, Meshulam Derazon S, Sharon E, Olshinka A.

Harefuah. 2016 Jul;155(7):435-438. Review. Hebrew.

PMID:
28514124
39.

Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial.

Shaashua L, Shabat-Simon M, Haldar R, Matzner P, Zmora O, Shabtai M, Sharon E, Allweis T, Barshack I, Hayman L, Arevalo J, Ma J, Horowitz M, Cole S, Ben-Eliyahu S.

Clin Cancer Res. 2017 Aug 15;23(16):4651-4661. doi: 10.1158/1078-0432.CCR-17-0152. Epub 2017 May 10.

40.

A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.

Yerushalmi R, Rizel S, Zoref D, Sharon E, Eitan R, Sabah G, Grubstein A, Rafson Y, Cohen M, Magen A, Birenboim I, Margel D, Ozlavo R, Sulkes A, Brenner B, Perry S.

Isr Med Assoc J. 2016 Sep;18(9):549-552.

41.

Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib.

Enewold L, Sharon E, Harlan LC.

Oncol Res Treat. 2017;40(4):174-183. doi: 10.1159/000456014. Epub 2017 Mar 9.

42.

Report on the FDA-AACR Immuno-oncology Drug Development Workshop.

Curran C, Sharon E.

Cancer Immunol Res. 2017 Apr;5(4):282-285. doi: 10.1158/2326-6066.CIR-17-0087.

43.

Commentary on Perez et al.: How to create a 21st century adverse event reporting system.

Sharon E.

Clin Trials. 2017 Jun;14(3):234-236. doi: 10.1177/1740774517700641. Epub 2017 Mar 26. No abstract available.

PMID:
28345419
44.

Can an Immune Checkpoint Inhibitor (Sometimes) Make Things Worse?

Sharon E.

Clin Cancer Res. 2017 Apr 15;23(8):1879-1881. doi: 10.1158/1078-0432.CCR-16-2926. Epub 2017 Mar 3.

45.

Corrigendum: Large-scale mapping of gene regulatory logic reveals context-dependent repression by transcriptional activators.

van Dijk D, Sharon E, Lotan-Pompan M, Weinberger A, Segal E, Carey LB.

Genome Res. 2017 Mar;27(3):500. doi: 10.1101/gr.220574.117. Epub 2017 Mar 1. No abstract available.

46.

Human Herpesvirus 6A Exhibits Restrictive Propagation with Limited Activation of the Protein Kinase R-eIF2α Stress Pathway.

Sharon E, Frenkel N.

J Virol. 2017 Apr 13;91(9). pii: e02120-16. doi: 10.1128/JVI.02120-16. Print 2017 May 1.

47.

Do women prefer a female breast surgeon?

Groutz A, Amir H, Caspi R, Sharon E, Levy YA, Shimonov M.

Isr J Health Policy Res. 2016 Dec 1;5:35. eCollection 2016.

48.

Large-scale mapping of gene regulatory logic reveals context-dependent repression by transcriptional activators.

van Dijk D, Sharon E, Lotan-Pompan M, Weinberger A, Segal E, Carey LB.

Genome Res. 2017 Jan;27(1):87-94. doi: 10.1101/gr.212316.116. Epub 2016 Dec 13. Erratum in: Genome Res. 2017 Mar;27(3):500.

49.

Internal Stresses Lead to Net Forces and Torques on Extended Elastic Bodies.

Aharoni H, Kolinski JM, Moshe M, Meirzada I, Sharon E.

Phys Rev Lett. 2016 Sep 16;117(12):124101. Epub 2016 Sep 16.

PMID:
27689279
50.

The rheology of a growing leaf: stress-induced changes in the mechanical properties of leaves.

Sahaf M, Sharon E.

J Exp Bot. 2016 Oct;67(18):5509-5515. Epub 2016 Sep 20.

Supplemental Content

Loading ...
Support Center